Skip to main content
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1992 Jan;35(1):14–18. doi: 10.1007/BF01741049

Tumor-derived cytokines induce bone marrow suppressor cells that mediate immunosuppression through transforming growth factor β

M Rita I Young 1,2,, Mark A Wright 1,2, Michael Coogan 1,2, Melvin E Young 1,2, Jamila Bagash 1,2
PMCID: PMC11038123  PMID: 1535284

Abstract

Normal bone marrow cells become immunosuppressive when cultured with supernatants of metastatic Lewis lung carcinoma (LLC-LN7) cells. The suppressorinducing activities in the LLC-LN7 supernatants are interleukin-3 and granulocyte/macrophage-colony-stimulating factor. In the present study, the mechanisms by which these induced suppressor cells (LLCsup-BM) mediate their immunosuppression were investigated. The suppression by LLCsup-BM of splenic concanavalin CA blastogenesis was not dependent on cell contact since immunosuppression occurred regardless of whether the LLCsup-BM were separated from the responder spleen cells by a permeable membrane or if the LLCsup-BM were cocultured with the spleen cells. Culture supernatants of LLCsup-BM also inhibited T cell blastogenesis, being more suppressive than were supernatants of control bone marrow cells, which had been precultured with medium. The suppression by the soluble inhibitors elaborated from the LLCsup-BM was not restricted to the inhibition of T cell function as the supernatants also inhibited the natural killer activity of normal spleen cells. Studies to determine the identity of the suppressive activity produced by the LLCsup-BM showed increased levels of transforming growth factor β (TGFβ) in their supernatants. Immunosuppressive bone marrow and spleen cells obtained from mice bearing metastatic LLC-LN7 tumors also secreted more TGFβ than did the cells obtained from normal mice. When anti-TGFβ antibodies were added to the LLCsup-BM supernatants, the suppressive activity was diminished. These results suggest that the LLCsup-BM mediate at least part of their immunosuppression through production of TGFβ.

Key words: Lewis lung carcinoma, TGFβ, Bone marrow, Immunosuppressor

Footnotes

This study was supported by the Medical Research Services of the Department of Veterans Affairs, and by grants CA-45080 and CA-48080 from the National Institutes of Health

References

  • 1.Awwad M, North RJ. Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4+ suppressor T-cells. Cancer Res. 1989;49:1649. [PubMed] [Google Scholar]
  • 2.Brooks B, Chapman K, Lawry J, Meager A, Rees RC. Suppression of lymphokine-activated killer (LAK) cell induction mediated by interleukin-4 and transforming growth factor-β1. effect of addition of exogenous tumour necrosis factor-alpha and interferongamma, and measurement of their endogenous production. Clin Exp Immunol. 1990;82:583. doi: 10.1111/j.1365-2249.1990.tb05494.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Chakraborty NG, Twardzik DR, Sivanandham M, Ergin MT, Hellstrom KE, Mukherji B. Autologous melanoma-induced activation of regulatory T cells that suppress cytotoxic response. J Immunol. 1990;145:2359. [PubMed] [Google Scholar]
  • 4.Clark DA, Falbo M, Rowley RB, Banwatt D, Stedronska-Clark J. Active suppression of host-vs-graft reaction in pregnant mice: IX. Soluble suppressor activity obtained from allopregnant mouse decidua that blocks the cytolytic effector response to IL-2 is related to transforming growth factor-β. J Immunol. 1988;141:3833. [PubMed] [Google Scholar]
  • 5.Cleveland MG, Lane RG, Klimpel GR. Spontaneous IFN-beta production. A common feature of natural suppressor systems. J Immunol. 1988;141:2043. [PubMed] [Google Scholar]
  • 6.Fu Y-X, Watson GA, Kasahara M, Lopez DM. The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma: I. Induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF. J Immunol. 1991;146:783. [PubMed] [Google Scholar]
  • 7.Geller RL, Smyth MJ, Strobl SL, Bach FH, Ruscetti FW, Longo DL, Ochoa AC. Generation of lymphokine-activated killer activity in T cells. Possible regulatory circuits. J Immunol. 1991;146:3280. [PubMed] [Google Scholar]
  • 8.Goey H, Keller JR, Back T, Longo DL, Ruscetti FW, Wiltrout RH. Inhibition of early murine hemopoietic progenitor cell proliferation after in vivo locoregional administration of transforming growth factor-β1. J Immunol. 1989;143:877. [PubMed] [Google Scholar]
  • 9.Hooper WC. The role of transforming growth factor-beta in hematopoiesis. A review. Leuk Res. 1991;15:179. doi: 10.1016/0145-2126(91)90118-d. [DOI] [PubMed] [Google Scholar]
  • 10.Jacobsen SE, Ruscetti FW, Dubois CM, Lee J, Boone TC, Keller JR. Transforming growth factor-beta trans-modulates the expression of colony stimulating factor receptors on murine hematopoietic progenitor cell lines. Blood. 1991;77:1706. [PubMed] [Google Scholar]
  • 11.Karpus WJ, Swanborg RH. CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-β. J Immunol. 1991;146:1163. [PubMed] [Google Scholar]
  • 12.Lotem J, Sachs L. Selective regulation of the activity of different hematopoietic regulatory proteins by transforming growth factor beta 1 in normal and leukemic myeloid cells. Blood. 1990;76:1315. [PubMed] [Google Scholar]
  • 13.Lotz M, Kekow J, Carson DA. Transforming growth factor-β and cellular immune responses in synovial fluids. J Immunol. 1990;144:4189. [PubMed] [Google Scholar]
  • 14.Maier T, Holda JH, Claman HN. Murine natural suppressor cells in the newborn, in bone marrow, and after cyclophosphamide. Genetic variations and dependence on IFN-gamma. J Immunol. 1989;143:491. [PubMed] [Google Scholar]
  • 15.Markovic SN, Murasko DM. Role of natural killer and T-cells in interferon induced inhibition of spontaneous metastases of the B16-F10L murine melanoma. Cancer Res. 1991;51:1124. [PubMed] [Google Scholar]
  • 16.Mortari F, Singhal SK. Production of human bone marrowderived suppressor factor. Effect on antibody synthesis and lectin-activated cell proliferation. J Immunol. 1988;141:3037. [PubMed] [Google Scholar]
  • 17.Nelson BJ, Ralph P, Green SJ, Nacy CA. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-β1. J Immunol. 1991;146:1849. [PubMed] [Google Scholar]
  • 18.Sakata T, Iwagami S, Tsuruta Y, Teraoka H, Hojo K, Suzuki S, Sato K, Suzuki R. The role of lipocortin I in macrophage-mediated immunosuppression in tumor-bearing mice. J Immunol. 1990;145:387. [PubMed] [Google Scholar]
  • 19.Sing GK, Keller JR, Ellingsworth LR, Ruscetti FW. Transforming growth factor-betal enhances the suppression of human hematopoiesis by tumor necrosis factor-alpha or recombinant interferon-alpha. J Cell Biochem. 1989;39:107. doi: 10.1002/jcb.240390203. [DOI] [PubMed] [Google Scholar]
  • 20.Smyth MJ, Strobl SL, Young HA, Ortaldo JR, Ochoa AC. Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta. J Immunol. 1991;146:3289. [PubMed] [Google Scholar]
  • 21.Tada T, Ohzeki S, Utsumi K, Takiuchi H, Maramatsu M, Li X-F, Shimizu J, Fujiwara H, Hamaoka T. Transforming growth factor-β-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state. J Immunol. 1991;146:1077. [PubMed] [Google Scholar]
  • 22.Tsuchiya Y, Igarashi M, Suzuki R, Kumagai K. Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells. J Immunol. 1988;141:699. [PubMed] [Google Scholar]
  • 23.Weingust RW, McCain GA, Singhal SK. Regulation of autoimmunity in normal and rheumatoid individuals by bone marrowderived natural suppressor cells and their suppressor factor: BDSF. Cell Immunol. 1989;122:154. doi: 10.1016/0008-8749(89)90156-1. [DOI] [PubMed] [Google Scholar]
  • 24.Young MR, Wheeler E, Newby M. Macrophage-mediated suppression of natural killer cell activity in mice bearing Lewis lung carcinoma. J Natl Cancer Inst. 1986;76:745. doi: 10.1093/jnci/76.4.745. [DOI] [PubMed] [Google Scholar]
  • 25.Young MR, Newby M, Wepsic HT. Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors. Cancer Res. 1987;47:100. [PubMed] [Google Scholar]
  • 26.Young MR, Aquino S, Young ME. Differential induction of hematopoiesis and immune suppressor cells in the bone marrow versus in the spleen by Lewis lung carcinoma variants. J Leuk Biol. 1989;452:262. doi: 10.1002/jlb.45.3.262. [DOI] [PubMed] [Google Scholar]
  • 27.Young MRI, Young ME, Wright MA. Stimulation of immune suppressive bone marrow cells by colony stimulating factors. Exp Hematol. 1990;18:806. [PubMed] [Google Scholar]
  • 28.Young MRI, Young ME, Wright MA. Myelopoiesis-associated suppressor cell activity in mice with Lewis lung carcinoma tumors: interferon-γ plus tumor necrosis factor-α synergistically reduce suppressor cell activity. Int J Cancer. 1990;46:245. doi: 10.1002/ijc.2910460217. [DOI] [PubMed] [Google Scholar]
  • 29.Young MRI, Wright MA, Young ME. Antibodies to colonystimulating factors block Lewis lung carcinoma cell-stimulation of immune suppressive bone marrow cells. Cancer Immunol Immunother. 1991;33:146. doi: 10.1007/BF01756134. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES